Completed PHASE2 INTERVENTIONAL 1-arm NCT02080221

BrUOG 292: FOLFOX-A For Metastatic Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial

Sponsor: Brown University

Interventions FOLFOXA

Updated 11 times since 2017 Last updated: Jul 27, 2022 Started: Aug 31, 2014 Primary completion: Jan 9, 2020 Completion: Mar 16, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Metastatic Pancreatic Cancer and is currently completed. Brown University leads this study, which shows 11 recorded versions since 2014 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

11 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Sep 2022 — Jul 2024 [monthly]

Completed PHASE2

Status: Active Not Recruiting → Completed
Sep 2021 — Sep 2022 [monthly]

Active Not Recruiting PHASE2
Jan 2021 — Sep 2021 [monthly]

Active Not Recruiting PHASE2

▶ Show 6 earlier versions

Mar 2020 — Jan 2021 [monthly]

Active Not Recruiting PHASE2

Status: Recruiting → Active Not Recruiting
May 2019 — Mar 2020 [monthly]

Recruiting PHASE2
Dec 2018 — May 2019 [monthly]

Recruiting PHASE2
Jun 2018 — Dec 2018 [monthly]

Recruiting PHASE2
Feb 2017 — Jun 2018 [monthly]

Recruiting PHASE2
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE2

First recorded

Aug 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Brown University
Lifespan
Memorial hospital
SouthCoast Medical Group

Data source: Brown University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Fairhaven, United States
• Providence, United States